Venture Life Group PLC UltraDEX update (8997U)
October 30 2017 - 2:00AM
UK Regulatory
TIDMVLG
RNS Number : 8997U
Venture Life Group PLC
30 October 2017
30 October 2017
Venture Life Group plc
("Venture Life" or "the Group")
UltraDEX update
Venture Life Group plc (AIM: VLG), the international consumer
self-care group focused on developing, manufacturing and
commercialising products for the ageing population, announces it
has reached an agreement for its first launch of the UltraDEX brand
into the convenience store channel.
Following a successful trial at one of their sites, the UK's
leading provider of motorway service stations, Moto Hospitality
Ltd., will launch UltraDEX mouth spray 9ml into WH Smith stores
across its 61 service station outlets, effective from 16 November
2017. The convenience store channel has not yet been exploited by
UltraDEX and offers a significant opportunity to access new
customers. Distribution will be managed by Albert Harrison &
Co. Ltd., which specialises in delivered wholesale of health &
beauty, confectionary and stationery products. This agreement paves
the way for future development of this important retail
channel.
Following new long term partnering agreements announced
previously this year, preparations for the new territories are on
track in France, Italy and the Nordics, where UltraDEX is expected
to be launched in Q1 2018.
Data from recent marketing activities has shown UltraDEX
continues to perform well against its competitors in the UK, and
the brand now has its highest ever level of listings
countrywide.
Jerry Randall, CEO of Venture Life commented: "Achieving this
first step onto the extensive convenience store channel has been a
significant win for UltraDEX. Moto is the leading provider of
convenience stores on the UK motorway network and enjoys meaningful
footfall. I am delighted with the continued commercial development
of the UltraDEX brand both in the UK and internationally, with the
brand preparing to launch in a number of new European markets in Q1
2018, including France and Italy."
For further information please contact:
+44 (0) 1344
Venture Life Group PLC 742870
Jerry Randall, Chief Executive Officer
Adrian Crockett, Chief Financial Officer
Northland Capital Partners Limited (Nominated Adviser +44 (0) 20
and Joint Broker) 3861 6625
Matthew Johnson / Edward Hutton (Corporate
Finance)
Bob Pountney / John Howes (Corporate
Broking)
+44 (0) 20
Turner Pope Investments (TPI) Ltd (Joint Broker) 3621 4120
James Pope / Ben Turner
Walbrook PR venturelife@walbrookpr.com
or
+ 44 (0) 20 7933 8780
Anna Dunphy / Paul McManus +44 (0) 7876 741 001 /
+44 (0) 7980 541 893
About Venture Life (www.venture-life.com)
Venture Life is an international consumer self-care company
focused on developing, manufacturing and commercialising products
for the ageing population. The Group's product portfolio includes
some key products such as the UltraDEX oral care products range,
food supplements for lowering cholesterol and maintaining brain
function, medical devices for women's intimate healthcare and
haemorrhoids and dermo-cosmetics for addressing the signs of
ageing.
The products, which are typically recommended by pharmacists or
healthcare practitioners, are available primarily through
pharmacies supplied by the Group's international distribution
partners.
Through its Development & Manufacturing business in Italy,
Biokosmes, the Group also provides development and manufacturing
services to companies in the medical devices and cosmetic
sectors.
This information is provided by RNS
The company news service from the London Stock Exchange
END
PRLFEEFAAFWSEIS
(END) Dow Jones Newswires
October 30, 2017 03:00 ET (07:00 GMT)
Venture Life (LSE:VLG)
Historical Stock Chart
From Apr 2024 to May 2024
Venture Life (LSE:VLG)
Historical Stock Chart
From May 2023 to May 2024